VivoSim Labs Inc. Common Stock (VIVS)

About VIVS

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

15

Website

organovo.com/

Fundamentals

1-day range

$0.285$0.2975

Market cap

$5.53M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-5.33

Dividend yield

—

Beta

1.50

Avg. volume

5.71M

Dividend pay date

August 19, 2020

VivoSim Labs Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• VIVS

  VivoSim Labs Inc. Common Stock

  $0.29

  ▲ 0.00%
  Market cap $5.53MP/E —
  $0.2625$5.3
• PHGE

  BiomX Inc. COmmon Stock

  $0.138

  ▲ 4.55%
  Market cap $3.95MP/E —
  $0.1192$12.29
• AIM

  AIM ImmunoTech Inc. Common Stock

  $0.2558

  ▲ 2.32%
  Market cap $7.51MP/E —
  $0.1901$2.89
• CRIS

  Curis Inc. Common Stock

  $1.49

  ▲ 2.76%
  Market cap $8.59MP/E —
  $1.4$39
• SCNI

  Scinai Immunotherapeutics Ltd. American Depositary Shares

  $2.53

  ▼ 5.60%
  Market cap $1.30MP/E 0.14
  $2.15$16.8
• BTTC

  Black Titan Corporation Ordinary Shares

  $0.4334

  ▼ 7.98%
  Market cap $1.02MP/E —
• BCDA

  BioCardia Inc. Common Stock

  $1.16

  ▼ 0.85%
  Market cap $10.80MP/E —
  $0.75$2.29

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Why Avalon Holdings Shares Are Trading Higher By More Than 10%; Here Are 20 Stocks Moving Premarket
  Benzinga · 8/10/2026
• VivoSim Labs Says It Regained Compliance With Nasdaq $2.5M Stockholders' Equity Rule After $5M Eli Lilly Milestone Payment, $4M Financing; Reports $10.1M Cash On Hand
  benzinga · 8/6/2026
• 12 Health Care Stocks Moving In Friday's Pre-Market Session
  Benzinga · 7/31/2026

Institutional Ownership

March 31, 2026

Total shares held

90.9K

Total value held

$130.0K

Institutional holders

23